Marketing-authorisation holder · Canada
Celystra Pharma Inc.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DAWNZERA80 mg / 0.8 ml · Solution | Donidalorsen | Canada | Authorised | |
| TRYNGOLZA80 mg / 0.8 ml · Solution | Olezarsen | Canada | Marketed | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Other haematological agentsBlood and blood-forming organs · ATC B06A
- Lipid-modifying agentsCardiovascular system · ATC C10A